Skip to main content

Table 2 Secondary outcomes for the study cohort

From: Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial

Variable

Control group

Prone group

P value

Count

39

36

 

Daily total prone time, hours

3.4 [1.8–8.4]

9.0 [4.4–10.6]

0.014

Total protocol duration, days

4.9 [2.3–8.1]

4.2 [1.7–5.7]

0.33

Daily prone time day 1–3, hours

2.6 [0.3–8.1]

8.5 [5.2–12.2]

0.001

30-day mortality

3 (8%)

6 (17%)

0.30

VFDa, all patients, days

30 [11–30]

30 [12–30]

0.69

VFDa, intubated patients, days

2 [1–10]

7 [0–20]

0.38

Days free from HFNO/NIVb

24 [22–26]

26 [23–28]

0.15

Enrolment to IMV, days

2 [1–6]

2 [1–5]

0.59

Use of NIV

27 (69%)

21 (58%)

0.33

Enrolment to NIV, days

0.25 [0.1–1.1]

0.23 [0.05–1.2]

0.63

Admitted to ICU

27 (69%)

27 (75%)

0.58

ICU LOS, days

11 [3–22]

5 [4–13]

0.25

ICU-free daysc

26 [8–30]

25 [14–28]

0.56

Hospital LOS, days

18 [11–30]

16 [11–22]

0.44

Vasoactive drugs

17 (44%)

13 (37%)

0.57

Sedation by continuous infusiond

14 (36%)

16 (44%)

0.45

Renal replacement therapy

1 (3%)

1 (3%)

ECMO

1 (3%)

0 (0%)

WHO clinical progression scale day 7, (0–10)

6 [6, 7]

6 [5–7]

0.35

WHO clinical progression scale, day 30, (0–10)

2 [2–6]

2 [2–4]

0.28

Adverse events

 Pressure sores

9 (23%)

2 (6%)

0.032

 Vomiting during proning

0 (0%)

1 (3%)

-

 Central or arterial line dislodgement

0 (0%)

0 (0%)

-

 Cardiac arrest within 30 days

1 (3%)

2 (6%)

0.51

 During proning

0 (0%)

0 (0%)

-

  1. Categorical parameters are presented as n (%), continuous variables as median (interquartile range [IQR]), VFD, Ventilator-Free Days; HFNO High-flow Nasal Oxygen; NIV, Noninvasive Ventilation; IMV, Invasive Mechanical Ventilation; ICU, Intensive Care Unit; LOS, Length of Stay; ECMO, Extracorporeal Membrane Oxygenation; WHO, World Health Organization
  2. aVentilator-free days were calculated for intubated (Control n = 13, Prone n = 12) and all patients, respectively, and defined as days free from invasive mechanical ventilation from enrollment until day 30. Patients who died were registered as 0 VFD
  3. bPatients who were not intubated. Calculated from enrollment until day 30. Control n = 26, Prone n = 24
  4. cDays when patients were not in the ICU. Patients who died were registered as 0 ICU-free days
  5. dNon-intubated patients during protocol